-
Je něco špatně v tomto záznamu ?
Catalog of exogenous risk factors for bladder carcinogenesis
V. Jahrreiss, B. Pradere, E. Laukhtina, K. Mori, SF. Shariat,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- karcinogeneze MeSH
- kouření škodlivé účinky MeSH
- lidé MeSH
- nádory močového měchýře chemicky indukované patologie MeSH
- pracovní expozice * MeSH
- prekancerózy chemicky indukované MeSH
- rizikové faktory MeSH
- vystavení vlivu životního prostředí škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
PURPOSE OF REVIEW: The aim of this article is to provide an overview of recent findings regarding the risk factors for bladder cancer. RECENT FINDINGS: Most of the available data derive from retrospective analysis. Smoking represents the most common and important risk factor. Occupational, dietary, and environmental exogenic carcinogen exposure, as well as several lifestyle factors, can increase the risk of developing bladder cancer. SUMMARY: Bladder cancer is a common malignancy worldwide. Cigarette smoking, exposure to aromatic amines and arsenic are known risk factors for bladder cancer. Evidence on other modifiable risk factors such as carcinogen exposure derived from the diet or environment as well as occupational hazards is still weak. Medical conditions leading to chronic inflammation, altering insulin resistance, negatively modulating the immune system and/or genetic alterations may have a role in bladder cancer carcinogenesis. Further studies are, however, necessary to identify possible exogenic risk factors, as well as their interactions, that partake in the carcinogenesis of bladder cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028202
- 003
- CZ-PrNML
- 005
- 20210114153221.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MOU.0000000000000753 $2 doi
- 035 __
- $a (PubMed)32235283
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jahrreiss, Victoria $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
- 245 10
- $a Catalog of exogenous risk factors for bladder carcinogenesis / $c V. Jahrreiss, B. Pradere, E. Laukhtina, K. Mori, SF. Shariat,
- 520 9_
- $a PURPOSE OF REVIEW: The aim of this article is to provide an overview of recent findings regarding the risk factors for bladder cancer. RECENT FINDINGS: Most of the available data derive from retrospective analysis. Smoking represents the most common and important risk factor. Occupational, dietary, and environmental exogenic carcinogen exposure, as well as several lifestyle factors, can increase the risk of developing bladder cancer. SUMMARY: Bladder cancer is a common malignancy worldwide. Cigarette smoking, exposure to aromatic amines and arsenic are known risk factors for bladder cancer. Evidence on other modifiable risk factors such as carcinogen exposure derived from the diet or environment as well as occupational hazards is still weak. Medical conditions leading to chronic inflammation, altering insulin resistance, negatively modulating the immune system and/or genetic alterations may have a role in bladder cancer carcinogenesis. Further studies are, however, necessary to identify possible exogenic risk factors, as well as their interactions, that partake in the carcinogenesis of bladder cancer.
- 650 _2
- $a karcinogeneze $7 D063646
- 650 _2
- $a vystavení vlivu životního prostředí $x škodlivé účinky $7 D004781
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a pracovní expozice $7 D016273
- 650 _2
- $a prekancerózy $x chemicky indukované $7 D011230
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a kouření $x škodlivé účinky $7 D012907
- 650 _2
- $a nádory močového měchýře $x chemicky indukované $x patologie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Pradere, Benjamin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Urology, CHRU Tours, François Rabelais University, Tours, France.
- 700 1_
- $a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
- 700 1_
- $a Mori, Keiichiro $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Urology, Weill Cornell Medical College, New York, New York, USA. Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Department of Urology, University of Jordan, Amman, Jordan. European Association of Urology research foundation, Arnhem, Netherlands.
- 773 0_
- $w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 30, č. 3 (2020), s. 449-456
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32235283 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114153218 $b ABA008
- 999 __
- $a ok $b bmc $g 1608537 $s 1119382
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 30 $c 3 $d 449-456 $e - $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
- LZP __
- $a Pubmed-20210105
